Vitamin D does not protect against dementia

There is no solid clinical evidence that vitamin D is a protective neurological agent, according to a new study published inNutritional Neuroscience.Medical Xpress
Source: Society for Endocrinology - Category: Endocrinology Source Type: news

Related Links:

This study was supported by the Fran and Ray Stark Foundation Fund for Alzheimer ’s Disease Research; the Parlow-Solomon and Plot Professorships; Bob and Marion Wilson; the Ahmanson Foundation; the National Institutes of Health; and the Department of Energy.The FDDNP tracer is intellectual property owned by UCLA and licensed to TauMark LLC. Barrio, Huang, Omalu, Satyamurthy and Small are co-inventors of the marker. Barrio, Fitzsimmons, Huang, Satyamurthy and Small have a financial interest in TauMark. Other disclosures are listed in the study.
Source: UCLA Newsroom: Health Sciences - Category: Universities & Medical Training Source Type: news
Authors: Reid SNS, Ryu JK, Kim Y, Jeon BH Abstract Considering the neuroprotective and antioxidant potential of fermented Laminaria japonica A. (FST), the purpose of the present study is to establish whether FST may be considered a viable, efficacious supplement that can be administered in later life to offset neurodegenerative conditions associated with aging. Forty senior subjects participated in a randomized, double-blind, and placebo-controlled study. Two groups were formed, one FST group (n = 32, 72.35 ± 5.54 yrs) and one placebo (CON) (n = 28, 74.57 ± 5.69 yrs), which received 1.5 g/day of FST f...
Source: Evidence-based Complementary and Alternative Medicine - Category: Complementary Medicine Tags: Evid Based Complement Alternat Med Source Type: research
Researchers from Yale University are reporting promising results with a PET...Read more on AuntMinnie.comRelated Reading: Are amyloid PET scans ready for the clinical setting? PET links amyloid, vascular factors to cognitive decline PET with novel tracers foretells early Alzheimer's risk PiB-PET study strengthens link between amyloid, dementia High amyloid levels on PET may indicate early Alzheimer's
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
DiscussionMidlife insomnia and late-life terminal insomnia or long sleep duration were associated with a higher late-life dementia risk.
Source: Alzheimer's and Dementia: The Journal of the Alzheimer's Association - Category: Geriatrics Source Type: research
Here's how government and healthcare leaders can integrate innovative approaches to dementia care into traditional models of care.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news
WHAT IS vascular dementia? With this type of dementia symptoms occur when the brain is damaged because of problems with the supply of blood to the brain. There are seven signs of the disease to watch out for in the early stages.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
  On May 4, 2018, I was honored to lead a session entitled “Dementia and Alzheimer’s Services @ Your Library” for approximately 40 front line library staff members attending the annual Reaching Forward Conference sponsored by the Illinois Library Association.  In addition to demonstrating how NLM databases such as Medline Plus can provide much needed medical information for those living with dementia and their care partners, I was also able to share some of the knowledge about dementia that I learned during the decade that I cared for my late husband who had been diagnosed with a young onset dem...
Source: The Cornflower - Category: Databases & Libraries Authors: Tags: Outreach Source Type: news
-- Delirium is a significant change in mental status, usually occurring during times of illness or stress, Health in Aging.org says. Delirium -- typically characterized by difficulty concentrating, changes in behavior or temperament, and an abrupt...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
To the Editor The Prophylactic Haloperidol Use for Delirium in ICU Patients at High Risk for Delirium (REDUCE) trial found that prophylactic haloperidol did not improve survival at 28 days compared with placebo. Despite the authors ’ attempt to capture an at-risk patient population, the enrolled patients did not have many of the risk factors known to be associated with the development of delirium. The mean age of enrolled patients was 67 years, baseline hypertension was not reported, and patients with a history of dementia, alcohol abuse, and psychiatric disorders were excluded. The mean Acute Physiology and Chronic ...
Source: JAMA - Category: General Medicine Source Type: research
Abnormalities in nucleic acid processing are associated with the development of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Mutations inMatrin 3 (MATR3), a poorly understood DNA- and RNA-binding protein, cause familial ALS/FTD, and MATR3 pathology is a feature of sporadic disease, suggesting that MATR3 dysfunction is integrally linked to ALS pathogenesis. Using a rat primary neuron model to assess MATR3-mediated toxicity, we noted that neurons were bidirectionally vulnerable to MATR3 levels, with pathogenic MATR3 mutants displaying enhanced toxicity. MATR3 ’s zinc finger domains partially m...
Source: eLife - Category: Biomedical Science Tags: Cell Biology Neuroscience Source Type: research
More News: Brain | Dementia | Endocrinology | Neurology | Study | Vitamin D | Vitamins